Delivery Order SPE2DB22D3301-SPE2DB25FX5GS

Award Date 11/12/24
Potential Completion Date 11/13/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXMEDETOMIDIN 400MCG/100ML-NS 100ML, a medical supply product, with a ceiling value of $2,093.78. The contract is a firm fixed price type, has an ultimate completion date of May 20, 2025, and is not set aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DEXMEDETOMIDIN 400MCG/100ML-NS 100ML, a pharmaceutical product, with a ceiling value of $3,018.78. The contract is a firm fixed-price delivery order with a performance period ending on June 30, 2025. This award is not set aside and represents an open competition contract. AmerisourceBergen Drug Corp is...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,543.69 firm fixed-price contract is for the supply of Dexmedetomidine 400mcg/100ml-NS 100ml, a medication used for sedation. The contract has an ultimate completion date of November 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXMEDETOMIDINE 200MCG/50ML-NS 50ML, a medical product, with a ceiling value of $1,305.37. The contract is a firm fixed price, non-set-aside award with a completion date of May 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order, valued at $2,705.43, is for the supply of the pharmaceutical product Dexmedetomidine 400mcg/100ml-NS 100ml. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a period of...
This is a firm fixed price delivery order (SPE2DB20D3103|SPE2DB24FN1G3) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $7,005.08 contract is for the delivery of 4564029850 - DEXMEDETOMIDINE 200 MCG/2 ML 2ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to Amerisourcebergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,906.46, is for the supply of Dexmedetomidine 400mcg/100ml-NS 100ml, a medication used for sedation. The award is not set-aside and is a firm fixed-price contract. It has an ultimate completion date of June 6, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no...
This federal contract award, valued at $14,711.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXMEDETOMIDINE 200 MCG/2 ML 2ML, a medication used in medical settings. The award, which does not have a set-aside designation, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,203,919 units of the pharmaceutical product Dexmedetomidine 200 mcg/2 ml 2 ml. The order has a ceiling value of $4,104.39 and a period of performance through April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4557189164 - DEXMEDETOMIDINE 200 MCG/2 ML 2ML. The contract, valued at $5,249.50, is a Firm Fixed Price Delivery Order with a completion date of May 12, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX5GS
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4566405650 - DEXMEDETOMIDIN 400MCG/100ML-NS 100ML pharmaceutical products. The contract has a firm fixed price of $3,303.46 and a completion date of November 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 5/20/25, 1:49 PM